Literature DB >> 1283780

Enzymatic inactivation of tachykinin neurotransmitters in the isolated spinal cord of the newborn rat.

M Yanagisawa1, K Yoshioka, T Kurihara, K Saito, N Seno, H Suzuki, R Hosoki, M Otsuka.   

Abstract

A mixture of peptidase inhibitors increased the magnitude of the saphenous nerve-evoked slow depolarization of a lumbar ventral root and prolonged the similarly evoked inhibition of monosynaptic reflex (MSR) in the isolated spinal cord of the newborn rat in the presence of naloxone. The saphenous nerve-evoked MSR inhibition was curtailed by a tachykinin antagonist, GR71251, and after the treatment with GR71251, the peptidase inhibitor mixture no more prolonged the MSR inhibition. The present results suggest that enzymatic degradation plays a role in the termination of action of tachykinins released from primary afferents in the newborn rat spinal cord. The results provide a further support for the notion that tachykinins serve as neurotransmitters in the spinal cord of the newborn rat.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283780     DOI: 10.1016/0168-0102(92)90050-m

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  3 in total

1.  Tachykininergic synaptic transmission in the coeliac ganglion of the guinea-pig.

Authors:  F Y Zhao; K Saito; K Yoshioka; J Z Guo; T Murakoshi; S Konishi; M Otsuka
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

2.  Effects of RP 67580, a tachykinin NK1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord.

Authors:  R Hosoki; M Yanagisawa; J Z Guo; K Yoshioka; T Maehara; M Otsuka
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

3.  Involvement of enzymatic degradation in the inactivation of tachykinin neurotransmitters in neonatal rat spinal cord.

Authors:  H Suzuki; K Yoshioka; M Yanagisawa; O Urayama; T Kurihara; R Hosoki; K Saito; M Otsuka
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.